韩国2018至2022年沙门菌血清型分布及耐药性
该研究分析了韩国9所大学医院2018至2022年分离的965株沙门菌,鉴定出58种血清型,最常见为肠炎沙门菌(21.5%)和I 4,[5],12:i:-(20.7%),对氨苄西林耐药率33.2%,环丙沙星中介耐药率32.8%,多重耐药率6.2%,广泛耐药率2.0%。结论强调需持续监测沙门菌血清型及耐药性以指导临床管理。
要点
- 韩国沙门菌以肠炎沙门菌和I 4,[5],12:i:-为主,前10种血清型占79.4%。
- 对氨苄西林耐药率33.2%,环丙沙星中介耐药率达32.8%。
- 多重耐药率6.2%,广泛耐药率2.0%,需持续监测。
核心结论
- 持续监测沙门菌血清型及抗菌药物耐药性对患者管理是必要的。
研究设计与样本
- 研究纳入韩国9所大学医院2018至2022年分离的965株沙门菌。
- 采用Kauffmann-White方案进行血清分型,使用Sensititre KRCDC2F药敏板进行抗菌药物敏感性试验。
主要发现
- 965株中732株(75.9%)来自粪便标本,233株(24.1%)来自血液标本,共鉴定出58种血清型。
- 最常见血清型为肠炎沙门菌(207株,21.5%)、I 4,[5],12:i:-(200株,20.7%)、婴儿沙门菌(88株,9.1%)、巴雷利沙门菌(77株,8.0%)和鼠伤寒沙门菌(69株,7.2%)。
- 对氨苄西林、氯霉素、甲氧苄啶-磺胺甲噁唑、头孢噻肟和头孢曲松的耐药率分别为33.2%、11.1%、8.2%、8.6%和8.3%。
- 对环丙沙星耐药率为3.0%,中介耐药率为32.8%;肠炎沙门菌环丙沙星非敏感率为93.7%,甲型副伤寒沙门菌环丙沙星耐药率为83.3%,伤寒沙门菌广泛耐药率为10.0%。
- 总体多重耐药率为6.2%(60株),广泛耐药率为2.0%(19株)。
临床怎么用
- 临床应关注沙门菌血清型分布及耐药趋势,尤其是环丙沙星中介耐药率高,经验用药需参考本地监测数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Salmonella is one of the main pathogens causing food-borne infectious diseases. We investigated the serotype distribution and antimicrobial resistance of Salmonella isolates in Korea obtained between 2018 and 2022. METHODS: We studied 965 Salmonella isolates from nine university hospitals across Korea. Serotypes were determined following the Kauffmann-White scheme, and antimicrobial susceptibility tests were performed using Sensititre KRCDC2F susceptibility testing plates. RESULTS: Of the 965 isolates, 732 (75.9%) were isolated from stool specimens, and 233 (24.1%) were isolated from blood specimens. We identified 58 different serotypes. The five most frequent serotypes detected were S. serovar Enteritidis (N=207; 21.5%), S. serovar I 4,[5],12:i:- (N=200; 20.7%), S. serovar Infantis (N=88; 9.1%), S. serovar Bareilly (N=77; 8.0%), and S. serovar Typhimurium (N=69; 7.2%). The 10 most common serotypes accounted for 79.4% of all isolates. The resistance rates to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, cefotaxime, and ceftriaxone were 33.2%, 11.1%, 8.2%, 8.6%, and 8.3%, respectively. Although only 3.0% of Salmonella isolates were resistant to ciprofloxacin, the intermediate resistance rate was 32.8%. We observed ciprofloxacin non-susceptibility (93.7%) in S. Enteritidis, ciprofloxacin resistance (83.3%) in S. serovar Paratyphi A, and extensive drug resistance (10.0%) in S. serovar Typhi. The overall rates of multidrug and extensive drug resistance were 6.2% (N=60) and 2.0% (N=19), respectively. CONCLUSIONS: Continuous monitoring of Salmonella serotypes for antimicrobial resistance is necessary for appropriate patient management.
引用
- Kim SM, Kim SH, Kim EY, et al. Serotype Distribution and Antimicrobial Resistance of Salmonella in Korea Between 2018 and 2022. Ann Lab Med. 2025. PMID: 41408861. doi:10.3343/alm.2025.0412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。